Market Leadership Hypera's positions as a leader in the OTC and prescription drug segments, coupled with iconic brands like Benegrip and Buscopan, present significant opportunities for expanding sales within retail pharmacies and healthcare providers seeking trusted, high-demand products.

Sustainability Edge Being listed in Brazil's top ESG companies underscores Hypera's commitment to sustainable practices, making it an attractive partner for clients and stakeholders prioritizing environmental and social responsibility in their procurement and investment decisions.

Growth Through Acquisition Hypera's ongoing acquisitions and internal development efforts suggest potential for introducing new or expanding product lines to existing customers, especially in dermocosmetics and institutional markets, providing avenues for increased revenue streams.

Digital Engagement With an active online presence and advanced usage of digital tools like Google Analytics and social media platforms, Hypera is well-positioned to leverage digital channels for targeted marketing and sales campaigns to healthcare professionals and consumers.

Recent Control Change The recent consolidation of a majority stake by new control groups indicates strategic shifts and growth ambitions, opening opportunities for partnership, co-marketing, and new market entry strategies aligned with Hypera's evolving corporate vision.